Ernesto Ulloa-Pérez, PhD is a postdoctoral researcher in the Department of Biostatistics, Epidemiology, and Informatics at the University of Pennsylvania, and is also a Center for Improving Care Delivery fellow at the Leonard Davis Institute of Health Economics. Dr. Ulloa-Pérez’s goal as a biostatistician is to perform research that empowers investigators and clinicians to enhance care delivery and improve health outcomes. His research focuses on causal inference, the use of electronic health record data, and health policy evaluation. Dr. Ulloa-Pérez is also passionate about science communication and is an active member of Mexicans in Statistics and Health, where he contributes to public outreach efforts. He earned his PhD in Biostatistics from the University of Washington and holds a ScB in Applied Mathematics from the Instituto Tecnológico Autónomo de México.
Associate Fellow
Ernesto Ulloa-Pérez, PhD
- Postdoctoral Fellow, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine
Related Content
Where There’s Smoke, There’s Less Maternity Care
Chart of the Day: New Study Maps Maternity Care Gaps in Smoke-Prone U.S. Counties
How the ‘One Big Beautiful Bill’ Could Gut the SNAP Food Program
Largest-Ever SNAP Cuts Could Trigger a Food Insecurity Crisis in Pennsylvania and Other States, Experts Warn in an Op-Ed on PennLive
How Medicaid Cuts Will Affect Quality and Access in Long-Term Care
Home Care May be Hardest Hit, LDI’s Rachel M. Werner Tells Marketplace’s Make Me Smart Podcast
A Bold Plan to Fix Medicaid
Democrats Must Go Beyond Reversing Trump-Era Cuts With a New Strategy to Streamline Coverage, Reduce Waste, and Expand Access to Medicaid
In The Media STAT
Oncologists Need to See Antimicrobial Resistance as a Cancer Care Delivery Crisis
Author
A Hidden Threat After Cancer: Food Insecurity and Early Death
Food-Insecure Cancer Survivors Live Shorter Lives, Especially if They Can’t Use Federal Programs Like SNAP
Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs
Memo: Delivered to the U.S. Food and Drug Administration (FDA)